ANF vs DAN

ANF has a stable Piotroski F-Score of 6/9, indicating moderate financial health, but lacks an Altman Z-Score, limiting definitive conclusions on bankruptcy risk. The stock trades above both the Graham Number ($81.46) and intrinsic value estimate ($71.89), suggesting overvaluation, despite strong profitability metrics like 40.89% ROE and 12.77% ROA. While revenue growth is positive at 6.80%, earnings are contracting YoY (-5.6%) and QoQ (-14.4%), and insider selling signals caution. Analysts recommend a 'buy' with a high target price of $127.56, but recent price performance shows significant short-term weakness (-24% in 1M).

Dana Incorporated exhibits severe fundamental weakness, highlighted by a Piotroski F-Score of 2/9, indicating poor financial health. Despite a massive 1-year price surge, the company suffers from a negative ROE (-4.27%), an alarmingly high Debt/Equity ratio of 3.94, and a dividend payout ratio of 90.91% that is likely unsustainable. The disconnect between the current price ($38.93) and the earnings track record—where the company has missed estimates in 4 of the last 4 quarters with an average surprise of -41.45%—suggests a momentum-driven bubble rather than value creation.